Anti-TB drugs can increase risk of TB re-infection

Current treatments for tuberculosis (TB) are very effective in controlling TB infection caused by Mycobacterium tuberculosis (Mtb). They don’t, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research. So why are our bodies unable to generate permanent immunity to TB, – the leading infectious disease killer worldwide? A…

When neurons are out of shape, antidepressants may not work

IMAGE: These are human serotonergic neuron projections (red) and cell bodies (green). view more  Credit: Salk Institute LA JOLLA–(March 22, 2019) Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed medication for major depressive disorder (MDD), yet scientists still do not understand why the treatment does not work in nearly thirty percent of patients with…

Sleep problems, Alzheimer’s disease are linked, but which comes first?

Rockville, Md. (March 22, 2019)–A new article explores the pathophysiological factors that link sleep disturbances and Alzheimer’s disease. Better understanding of this connection may lead to potential diagnostics and therapeutics for Alzheimer’s disease and other neurodegenerative diseases and dementia. The article is published ahead of print in the Journal of Neurophysiology (JNP). Alzheimer’s research has…

Genetesis CardioFlux™ platform receives FDA 510(k) clearance

IMAGE: Patient, monitored by nurse, in a Genetesis Cardioflux™ scanner. view more  (Mason, OH March 22, 2019 8 am) Genetesis, a medical technology company focused on using biomagnetic imaging to enable rapid, noninvasive and accurate chest pain triage, has received FDA 510(k) clearance for its cardiac imaging platform. The platform pairs the CardioFlux™ Magnetocardiograph with the…